Jim Turner Professor of Cognitive Disorders, Professor of Psychiatry, Pharmacology, and Medicine, Director, Vanderbilt Center for Cognitive Medicine, Vanderbilt University School of Medicine
Psychiatry
Dr. Paul A. Newhouse, MD
|
|
Give Review
Dr. Paul A. Newhouse practices Psychiatry. He went to Loyola University Chicago Stritch School of Medicine. He over the years received 9 awards: "Member", "Fellow", "Excellence in Psychiatry Academic Teaching Award", "Profile of Courage Award", "Exemplary Psychiatrist Award", "Best Doctors in America", "Excellence in Psychiatry Teaching Award", "Army Achievement Medal" and "Meritorious Service Medal". Paul A. Newhouse is a published MD as well. He has 89 publications published. The latest was: The intrapulmonary percussive ventilator and flutter device compared to standard chest physiotherapy in patients with cystic fibrosis.
Publications
- Impaired Working Memory in Geriatric Depression: An fMRI Study.
- Mild cognitive impairment: diagnosis, longitudinal course, and emerging treatments.
- Deficits in audiovisual speech perception in normal aging emerge at the level of whole-word recognition.
- Cognitive-behavioral therapy increases prefrontal cortex gray matter in patients with chronic pain.
- COGNITION AS A THERAPEUTIC TARGET IN LATE-LIFE DEPRESSION: POTENTIAL FOR NICOTINIC THERAPEUTICS.
- Tamoxifen Improves Cholinergically Modulated Cognitive Performance in Postmenopausal Women.
- Chemotherapy altered brain functional connectivity in women with breast cancer: a pilot study.
- AZD3480, a Novel Nicotinic Receptor Agonist, for the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults.
- Increased working memory-related brain activity in middle-aged women with cognitive complaints.
- Organizational Structure Reduces Processing Load in the Prefrontal Cortex During Discourse Processing of Written Text: Implications for High-Level Reading Issues After...
- The Effects of Age and Estrogen on Stress Responsivity in Older Women.
- Manipulation of nicotinic acetylcholine receptors differentially affects behavioral inhibition in human subjects with and without disordered baseline impulsivity.
- Functional brain imaging of nicotinic effects on higher cognitive processes.
- The cholinergic hypothesis of cognitive aging revisited again: Cholinergic functional compensation.
- Increased memory load-related frontal activation after estradiol treatment in postmenopausal women.
- Estrogen treatment impairs cognitive performance after psychosocial stress and monoamine depletion in postmenopausal women.
- Cholinergic modulation of hippocampal activity during episodic memory encoding in postmenopausal women: a pilot study.
- Summary of the National Institute on Aging-sponsored conference on depressive symptoms and cognitive complaints in the menopausal transition.
- Benefits of a telepsychiatry consultation service for rural nursing home residents.
- Ichi, Ni, 3, 4: neural representation of kana, kanji, and Arabic numbers in native Japanese speakers.
- The Stroop effect in kana and kanji scripts in native Japanese speakers: an fMRI study.
- Estrogen administration negatively alters mood following monoaminergic depletion and psychosocial stress in postmenopausal women.
- Nicotinic versus muscarinic blockade alters verbal working memory-related brain activity in older women.
- Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorder.
- Sex differences in psychophysical and neurophysiological responses to pain in older adults: a cross-sectional study.
- Effects of acute ultra-low dose mecamylamine on cognition in adult attention-deficit/hyperactivity disorder (ADHD).
- Broad spectrum assessment of psychopathology and adaptive functioning with the Older Adult Behavior Checklist: a validation and diagnostic discrimination study.
- Central nicotinic cholinergic systems: a role in the cognitive dysfunction in attention-deficit/hyperactivity disorder?
- Effects of nicotinic stimulation on cognitive performance.
- Effects of acute nicotine administration on behavioral inhibition in adolescents with attention-deficit/hyperactivity disorder.
- Nicotinic acetylcholine receptor system and neuropsychiatric disorders.
- Estrogen treatment effects on anticholinergic-induced cognitive dysfunction in normal postmenopausal women.
- Sex differences in visual-spatial learning using a virtual water maze in pre-pubertal children.
- Estradiol interacts with the cholinergic system to affect verbal memory in postmenopausal women: evidence for the critical period hypothesis.
- Alzheimer disease, serotonin systems, and tryptophan depletion.
- An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression.
- Nicotine and nicotinic receptor involvement in neuropsychiatric disorders.
- Effects of galantamine on measures of attention: results from 2 clinical trials in Alzheimer disease patients with comparisons to donepezil.
- Nicotinic systems in central nervous systems disease: degenerative disorders and beyond.
- The effects of nicotine on Parkinson's disease.
- Nicotinic treatment for degenerative neuropsychiatric disorders such as Alzheimer''s disease and Parkinson''s disease.
- A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients.
- Nicotinic treatment of Alzheimer's disease.
- High-dose selegiline in treatment-resistant older depressive patients.
- Decoupling motor memory strategies: effects of sleep deprivation and amphetamine.
- Age-related effects of the nicotinic antagonist mecamylamine on cognition and behavior.
- Use of serotonin selective reuptake inhibitors in geriatric depression.
- Nicotinic system involvement in Alzheimer''s and Parkinson''s diseases. Implications for therapeutics.
- The intrapulmonary percussive ventilator and flutter device compared to standard chest physiotherapy in patients with cystic fibrosis.
- Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer''s disease.
- Acute nicotinic blockade produces cognitive impairment in normal humans.
- Parsing attentional components during a simple reaction time task using sleep deprivation and amphetamine intervention.
- Adjunctive treatment of manic agitation with lorazepam versus haloperidol: a double-blind study.
- The role of nicotine and nicotinic mechanisms in neuropsychiatric disease.
- Neuroendocrine, physiologic, and behavioral responses following intravenous nicotine in nonsmoking healthy volunteers and in patients with Alzheimer''s disease.
- A preliminary study of the effects of nighttime administration of the serotonin agonist, m-CPP, on sleep architecture and behavior in healthy volunteers.
- Cholinergic drug studies in dementia and depression.
- Implicit learning in patients with Alzheimer''s disease.
- Dose-dependent effects of deprenyl on CSF monoamine metabolites in patients with Alzheimer''s disease.
- Acute effects of high-dose thyrotropin releasing hormone infusions in Alzheimer''s disease.
- Low-dose oral lorazepam administration in Alzheimer subjects and age-matched controls.
- The effects of d-amphetamine on arousal, cognition, and mood after prolonged total sleep deprivation.
- Clock drawing in Alzheimer's disease. A novel measure of dementia severity.
- CSF somatostatin in patients with Alzheimer's disease, older depressed patients, and age-matched control subjects.
- A preliminary study of the effects of intravenous m-chlorophenylpiperazine, a serotonin agonist, in elderly subjects.
- Design and interpretation of opiate antagonist trials in dementia.
- Multiple-dose arecoline infusions in Alzheimer's disease.
- The effects of acute scopolamine in geriatric depression.
- Differential responsivity of mood, behavior, and cognition to cholinergic agents in elderly neuropsychiatric populations.
- Prolactin response to TRH in Alzheimer's disease and elderly controls.
- Thyrotropin-releasing hormone and dementia.
- L-deprenyl in Alzheimer's disease. Preliminary evidence for behavioral change with monoamine oxidase B inhibition.
- Tranylcypromine compared with L-deprenyl in Alzheimer's disease.
- Intravenous nicotine in Alzheimer''s disease: a pilot study.
- A new scale for the assessment of depressed mood in demented patients.
- Pharmacologic modelling of Alzheimer''s disease.
- Failure of high dose naloxone to relieve tardive dyskinesia.
- Intravenous nicotine in a patient with Alzheimer's disease.
- Mental health care in European military communities.
- Division psychiatrists in peacetime.
- TRH stimulation test in dementia of the Alzheimer type and elderly controls.
- Pharmacologic characterization and lecithin treatment of a patient with spontaneous oral-facial dyskinesia and dementia.
- Extended-release physostigmine in Alzheimer disease: a multicenter, double-blind, 12-week study with dose enrichment. Physostigmine Study Group.
- Society for Research on Nicotine and Tobacco.
- No evidence for a higher resting metabolic rate in noninstitutionalized Alzheimer's disease patients.
- Daily energy expenditure in free-living non-institutionalized Alzheimer's patients: a doubly labeled water study.
- DHEA treatment of Alzheimer''s disease: a randomized, double-blind, placebo-controlled study.
- Nicotine treatment of mild cognitive impairment: a 6-month double-blind pilot clinical trial.
Schools
Loyola University of Chicago Stritch School of Medicine
Loyola University Med Center
Walter Reed Amc
National Institute Mntl Health
Procedures Preformed
- Psychiatric Evaluation
Doctors Specialties
- Geriatric Psychiatry
- Psychiatry
Accepted Insurances
Awards
- Member
- Fellow
- Excellence in Psychiatry Academic Teaching Award
- Profile of Courage Award
- Exemplary Psychiatrist Award
- Best Doctors in America
- Excellence in Psychiatry Teaching Award
- Army Achievement Medal
- Meritorious Service Medal
Education
-
National Institutes of Health Clinical Center -
Loyola University Chicago Stritch School of Medicine
Drug Facts
| NPI NUMBER | 1962596734 | |
| NPPES Provider LastName | NEWHOUSE | |
| NPPES Provider FirstName | PAUL | |
| NPPES Provider ZIPCode | 372320001 | |
| NPPES Provider State | TN | |
| Specialty Description | Geriatric Psychiatry | |
| Total Claim Count | 18.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1962596734 |
| Last Name Of The Provider | NEWHOUSE |
| First Name Of The Provider | PAUL |
| View All |
Similar Doctors
|
|
Dr. William S. West, MD |
|
|
Dr. Mi Yu, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Joseph M. Sharpe, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexander Prikhojan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paula S. Nunn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Keith G. Meador, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Andrei Avenido, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin A. Wellen, MD |
|
|
Richard H. Carlson Jr. |